Add like
Add dislike
Add to saved papers

[Diagnostic classification of intracranial meningiomas in the serial angiogram].

On the basis of 70 serial angiograms of surgically and histologically reliably diagnosed intracranial meningiomas and the appertaining general radiographs of the skull the following was found: 48.5 per cent of the general radiographs showed reactions, 7.1 per cent showed tumour calcifications. Basal meningiomas of the anterior and medium cranial fossae and meniogiomas of the wings of the sphenoid bone are supplied by the a. carotis interna, that is to say, they are also diagnosed by the internal carotid angiography. In serial angiograms, classification was possible in 74 per cent. The other supratentorial meningiomas require angiographies of the external or the common carotid. Infratentorial menigiomas were diagnosed in 50 per cent of the angiograms. The "early vein" is no reliable sign of malignity of the menigiomas. The same applies to "apthologic vessels", "shunts", etc. Staining does not give any secure indications of histological structures.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app